News

Roswell Park Introduces Gyn-Onc Connect Line for Consultation

To better service community practitioners, Roswell Park Comprehensive Cancer Center is proud to introduce Gyn-Onc Connect, a dedicated phone number to access Roswell Park’s gynecologic oncology team.

Video

Case Study: BRCA Mutation Led To Early Detection of Pre-Ovarian Cancer Condition

A 59-year-old woman was referred to Nicole Gaulin, MD, a gynecologic oncologist at Roswell Park Comprehensive Cancer Center, after learning she had a BRCA2 mutation linked with both breast cancer in a cousin and colon cancer in her father.

Video

Roswell Park Launches Exclusive Phase 1 Clinical Trial of ‘Armored’ CAR T-Cell Therapy for Ovarian Cancer

Roswell Park Comprehensive Cancer Center is currently recruiting for a phase 1 clinical trial of the new therapy (NCT07489287), called GB-5267, which was co-developed by Roswell Park and the therapeutics company Generate:Biomedicines.

News

Roswell Park at ASCO 2026: GLP-1s and Aggressive Breast Cancer, CAR T in Older Adults, AI-Informed Benchmarking

The research findings of experts from Roswell Park Comprehensive Cancer Center will be featured during the American Society of Clinical Oncology (ASCO) annual meeting May 29 to June 2 at McCormick Place in Chicago

News

Miss Us at ASCO? Join Us for A Year in Review This September

Reflect on the latest research presented at this year’s ASCO conference and discuss what’s next at Roswell Park Oncology Year-In-Review, scheduled for Saturday, September 26 in Buffalo, NY.

Video

New Trial for Rare Brain Lymphoma Open at Roswell Park

Roswell Park Comprehensive Cancer Center is one of four locations in the United States and Europe in which patients with relapsed or refractory non-Hodgkin lymphoma in their central nervous system can access a new clinical trial, led by ...